AbClon Competitors and Similar CompaniesClear all
AbClon's competitors and similar companies include Creative Bio-Peptides and Upstream Bio.
 Creative Bio-Peptides Creative Bio-Peptides (CBP) is a company that develops disease-modifying oral chemokine antagonist peptides that repair and regenerate damaged neurons. |  Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ||
Founding Date | Founding Date 2010 | Founding Date 2017 | Founding Date 2021 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations KR HQ | Locations Rockville, US HQ | Locations Waltham, US HQ |
Employees | Employees N/A | Employees 4 | Employees 38 |
Financial | |||
Revenue (est.) | Revenue (est.) ₩2.3b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $2.9m (FY, 2025) |
Cost of goods | Cost of goods (₩74.1m) (FY, 2024) | Cost of goods N/A | Cost of goods $23m (FY, 2025) |
Gross profit | Gross profit ₩2.4b (FY, 2024) | Gross profit N/A | Gross profit ($20.2m) (FY, 2025) |
Net income | Net income (₩16.3b) (FY, 2024) | Net income N/A | Net income ($143.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Creative Bio-Peptides
HQ
Rockville, US
Employees
4
Creative Bio-Peptides (CBP) is a company that develops disease-modifying oral chemokine antagonist peptides that repair and regenerate damaged neurons.
View companyUpstream Bio
HQ
Waltham, US
Employees
38
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company